Innovative new approach to constructing a nose in young patients with arhinia

Congenital arhinia (meaning patients born without a nose) is a rare condition associated with high mortality if not identified. As most babies when born are obligate nose breathers, the condition requires immediate attention. The clinical condition is a very rare genetic disorder that, in severe cases, causes congenital absence of the nose with life threatening conditions. In a new report in The Journal of Craniofacial Surgery, an expert team of plastic and cranio-maxillofacial surgeons describes an innovative new approach to constructing a nose in two young patients with arhinia. The journal is published in the Lippincott portfolio by Wolters Kluwer. The condition involves function and appearance.

Eric C. Liao, MD, PhD, of Massachusetts General Hospital/Harvard Medical School and colleagues report on two patients from a family affected by congenital arhinia, and the surgical technique designed to create a cosmetically acceptable nose. The experience "highlights key principles of a staged approach to nasal construction in arhinia and discusses nuances and improvements learned between both patients," the researchers write.

Newly recognized mutation leads to congenital arhinia

"Arhinia is an extremely rare congenital condition with fewer than 100 cases reported in the literature worldwide," according to the authors. Only a few reports have described approaches to nasal construction in patients with complete arhinia – the condition is so rare that the operation is usually designed on a case-by-case basis.

Congenital arhinia is caused by mutations of a gene called SMCHD1. In the two new patients, modern genetic testing techniques identified a previously unknown SMCHD1 mutation. Congenital arhinia may take different forms: the mother of one of the patients had no sense of smell (anosmia), and another affected family member died. Even though it includes just two patients, the new article "is the largest pedigree of such cases in the literature."

Not only was the external nose absent, but the skeletal foundation of the midface was severely underdeveloped. The two patients had no facial air passages, so the newly created nose was nonfunctional; the patients were able to breathe through the mouth.

Staged technique enables successful construction of the nose

To meet the complex challenges posed by this severe defect, Dr. Liao and colleagues designed a staged approach to augment the underlying bones of the face and to construct an external nose. In the first stage, the patients underwent midface skeletal advancement using a standard technique (Le Fort II osteotomy), including placement of external distraction hardware to create new bone for use in reconstruction.

After a few months of healing, a tissue expander was placed under the skin of the forehead to create new soft tissue. In another few months, the new nose was created by placing this forehead tissue flap over a costochondral framework, crafted by surgeons using rib cartilage. Final steps consisted of further skin grafts to refine the appearance of the nasal tip. Experience in the first case enabled the surgeons to refine their approach in the second patient.

The procedure created "an aesthetically pleasing shape of the external nose," improving the patients' facial appearance and lessening the social impact of their deformity. The researchers write, "Both subjects recovered from the staged procedures without any postoperative complications and are pleased with their progress so far."

The approach developed in the new report "represents a unique and important opportunity to highlight key principles of nasal construction in arhinia," Dr. Liao and coauthors write. They add, "This guide offers an optimized guide to this surgical strategy for improved aesthetic and functional outcomes in these patients."

Journal reference:

Bargiela, M., et al. (n.d.). Nasal Construction in Congenital Arhinia Due to Novel SMCHD1 Gene Variant. Journal of Craniofacial Surgery.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of AZoLifeSciences.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rare YKT6 Gene Variants Linked to New Neurological Disorder